Physician profile
Rebecca E Dade
NPI 1891110805
$1,762.84
in general payments reported to CMS, 2019-2025
20 companies · $567 in 2025
The $567 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $458 · 2022: $88.24 · 2023: $30.82 · 2024: $620 · 2025: $567.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,216.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $463.96 | 2021-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $321.49 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Dexcom, INC. | $265.88 | 2024-2025 | Dexcom G6 Transmitter |
| Insulet Corporation | $103.19 | 2021-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $89.73 | 2021-2025 | Recorlev, Gvoke Hypopen |
| Medtronic, INC. | $65.99 | 2024 | Minimed 780g, Intellis Adaptivestim |
| Bayer Healthcare Pharmaceuticals INC. | $63.61 | 2024-2025 | |
| Radius Health, INC. | $59.81 | 2024 | Tymlos |
| Amgen INC. | $52.52 | 2021-2025 | Tepezza |
| Cequr Corporation | $47.60 | 2024-2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $46.22 | 2021-2024 | |
| Kyowa Kirin, INC. | $32.96 | 2025 | |
| Alexion Pharmaceuticals, INC. | $30.84 | 2024 | Strensiq |
| Abbvie INC. | $26.75 | 2021 | |
| Lilly USA, LLC | $20.76 | 2024 | Jardiance |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $17.46 | 2021 | |
| Ibsa Pharma INC. | $14.10 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.67 | 2021 | |
| Amneal Pharmaceuticals LLC | $13.48 | 2024 | Unithroid |
| Amarin Pharma, INC. | $12.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Dade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.